PMID- 22824512 OWN - NLM STAT- MEDLINE DCOM- 20121207 LR - 20120822 IS - 1090-2422 (Electronic) IS - 0014-4827 (Linking) VI - 318 IP - 18 DP - 2012 Nov 1 TI - Establishment and characterization of mouse bone marrow-derived mast cell hybridomas. PG - 2385-96 LID - 10.1016/j.yexcr.2012.07.010 [doi] AB - Interleukin (IL)-3-dependent mouse bone marrow-derived mast cells (BMMCs) are an important model for studying the function of mucosal-type mast cells. In the present study, BMMCs were successfully immortalized by cell fusion using a hypoxanthine-aminopterin-thymidine medium-sensitive variant of P815 mouse mastocytoma (P815-6TgR) as a partner cell line. The established mouse mast cell hybridomas (MMCHs) expressed alpha, beta, and gamma subunits of high-affinity immunoglobulin E (IgE) receptor (FcepsilonRI) and possessed cytoplasmic granules devoid of or partially filled with electron-dense material. Four independent MMCH clones continuously proliferated without supplemental exogenous IL-3 and showed a degranulation response on stimulation with IgE+antigen. Furthermore, histamine synthesis and release by degranulation were confirmed in MMCH-D5, a MMCH clone that showed the strongest degranulation response. MMCH-D5 exhibited elevated levels of IL-3, IL-4, IL-13, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor (TNF)-alpha, and cyclooxygenase 2, and production of prostaglandin D(2) and leukotriene C(4) in response to IgE-induced stimulation. MMCH clones also expressed Toll-like receptors (TLRs) 1, 2, 4, and 6 and showed elevated levels of TNF-alpha expression in response to stimulation with TLR2 and TLR4 ligands. The MMCHs established using this method should be suitable for studies on FcepsilonRI- and TLR-mediated effector functions of mast cells. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Kawahara, Takeshi AU - Kawahara T AD - Integrated Department of Sciences of Functional Foods, Graduate School of Agriculture, Shinshu University, Nagano, Japan. tkawafb@shinshu-u.ac.jp LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120721 PL - United States TA - Exp Cell Res JT - Experimental cell research JID - 0373226 RN - 0 (Antigens, CD) RN - 0 (Fc(alpha) receptor) RN - 0 (Ligands) RN - 0 (Receptors, Fc) RN - 0 (Receptors, IgE) RN - 0 (Toll-Like Receptors) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Antigens, CD/genetics/metabolism MH - Bone Marrow Cells/*cytology/metabolism MH - Cell Degranulation MH - Hybridomas/*cytology/metabolism MH - Ligands MH - Mast Cells/cytology/*metabolism MH - Mice MH - Receptors, Fc/genetics/metabolism MH - Receptors, IgE/immunology/metabolism MH - Toll-Like Receptors/metabolism MH - Tumor Necrosis Factor-alpha/metabolism EDAT- 2012/07/25 06:00 MHDA- 2012/12/12 06:00 CRDT- 2012/07/25 06:00 PHST- 2012/05/15 00:00 [received] PHST- 2012/07/09 00:00 [revised] PHST- 2012/07/12 00:00 [accepted] PHST- 2012/07/25 06:00 [entrez] PHST- 2012/07/25 06:00 [pubmed] PHST- 2012/12/12 06:00 [medline] AID - S0014-4827(12)00330-8 [pii] AID - 10.1016/j.yexcr.2012.07.010 [doi] PST - ppublish SO - Exp Cell Res. 2012 Nov 1;318(18):2385-96. doi: 10.1016/j.yexcr.2012.07.010. Epub 2012 Jul 21.